ALKEM LABORATORIES LTD. vs CIPLA LTD

A side-by-side comparison of ALKEM LABORATORIES LTD. (ALKEM) and CIPLA LTD (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

ALKEM LABORATORIES LTD. and CIPLA LTD are evenly matched on the numbers (77). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

28.90
P/E ratio
29.54
4.76
P/B ratio
3.42
0.76%
Dividend yield
0.90%
₹192.51
EPS
₹48.02

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

18.90%
Return on equity
11.60%
21.00%
Return on capital
15.00%
20.00%
EBITDA margin
21.00%
15.98%
Net margin
13.71%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

8.25%
Revenue CAGR (3Y)
7.37%
32.66%
Profit CAGR (3Y)
10.88%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹66,516 Cr
Market cap
₹1.15L Cr
₹14,712 Cr
Revenue
₹28,163 Cr
₹2,351 Cr
Net profit
₹3,862 Cr
0.15
Debt / equity
0.02
ALKEM LABORATORIES LTD.
  • + ["Company has been maintaining a healthy dividend payout of 26.3%"]
  • ["Promoter holding has decreased over last quarter: -1.50%", "The company has delivered a poor sales growth of 10.7% over past five years."]
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.34%"]
ALKEM LABORATORIES LTD. full analysis CIPLA LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

ALKEM LABORATORIES LTD. vs CIPLA LTD: Share Price, Valuation & Which to Buy | DocStoX